Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Above-Label Octreotide-LAR in Carcinoid Syndrome
NCT01886287Phase 2Terminated
- Sponsor
- Moffitt Cancer Center
- Start
- Dec 2013
- Primary completion
- Aug 2014
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of octreotide in Carcinoid Syndrome (CS), sponsored by Moffitt Cancer Center. Started Dec 2013; status: terminated.
02
Drugs
octreotide
03
Conditions
Carcinoid Syndrome (CS)
Beyond the preview
Go deeper on NCT01886287.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01886287.